

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fat-soluble vitamin metabolic process (GO:0006775) | 8.61657765 |
| 2 | tyrosine metabolic process (GO:0006570) | 8.44451958 |
| 3 | detection of light stimulus involved in sensory perception (GO:0050962) | 8.04498139 |
| 4 | detection of light stimulus involved in visual perception (GO:0050908) | 8.04498139 |
| 5 | primary alcohol metabolic process (GO:0034308) | 6.98018362 |
| 6 | retinoic acid metabolic process (GO:0042573) | 6.03993191 |
| 7 | camera-type eye morphogenesis (GO:0048593) | 5.27429167 |
| 8 | secondary metabolic process (GO:0019748) | 5.12533533 |
| 9 | phototransduction, visible light (GO:0007603) | 4.99287575 |
| 10 | cellular aldehyde metabolic process (GO:0006081) | 4.91595028 |
| 11 | phenol-containing compound biosynthetic process (GO:0046189) | 4.82329866 |
| 12 | retinoid metabolic process (GO:0001523) | 4.81677996 |
| 13 | retina homeostasis (GO:0001895) | 4.66098142 |
| 14 | diterpenoid metabolic process (GO:0016101) | 4.49896959 |
| 15 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 4.47789544 |
| 16 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 4.47789544 |
| 17 | tachykinin receptor signaling pathway (GO:0007217) | 4.45531056 |
| 18 | mitochondrion distribution (GO:0048311) | 4.45137077 |
| 19 | * phototransduction (GO:0007602) | 4.45125888 |
| 20 | melanocyte differentiation (GO:0030318) | 4.29592171 |
| 21 | detection of visible light (GO:0009584) | 4.28751382 |
| 22 | diterpenoid biosynthetic process (GO:0016102) | 4.16750510 |
| 23 | terpenoid metabolic process (GO:0006721) | 4.15753055 |
| 24 | homocysteine metabolic process (GO:0050667) | 4.13263562 |
| 25 | primary amino compound metabolic process (GO:1901160) | 4.03005472 |
| 26 | * detection of light stimulus (GO:0009583) | 4.02142677 |
| 27 | vitamin A metabolic process (GO:0006776) | 33.7022475 |
| 28 | bicarbonate transport (GO:0015701) | 3.98855931 |
| 29 | ear development (GO:0043583) | 3.97096475 |
| 30 | indole-containing compound catabolic process (GO:0042436) | 3.92504090 |
| 31 | indolalkylamine catabolic process (GO:0046218) | 3.92504090 |
| 32 | tryptophan catabolic process (GO:0006569) | 3.92504090 |
| 33 | microtubule nucleation (GO:0007020) | 3.92104116 |
| 34 | pigment cell differentiation (GO:0050931) | 3.90756760 |
| 35 | photoreceptor cell maintenance (GO:0045494) | 3.90588132 |
| 36 | adenosine metabolic process (GO:0046085) | 3.88804571 |
| 37 | gamma-aminobutyric acid transport (GO:0015812) | 3.83322404 |
| 38 | behavioral response to nicotine (GO:0035095) | 3.76535127 |
| 39 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.74699626 |
| 40 | response to electrical stimulus (GO:0051602) | 3.73205145 |
| 41 | ketone body metabolic process (GO:1902224) | 3.72055349 |
| 42 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.69327765 |
| 43 | indolalkylamine metabolic process (GO:0006586) | 3.64404024 |
| 44 | retinal rod cell development (GO:0046548) | 3.56285677 |
| 45 | kynurenine metabolic process (GO:0070189) | 3.51805070 |
| 46 | cochlea development (GO:0090102) | 3.50035600 |
| 47 | cysteine metabolic process (GO:0006534) | 3.45197201 |
| 48 | sulfur amino acid catabolic process (GO:0000098) | 3.40150887 |
| 49 | adaptation of signaling pathway (GO:0023058) | 3.37621819 |
| 50 | isoprenoid metabolic process (GO:0006720) | 3.34796241 |
| 51 | * visual perception (GO:0007601) | 3.33060729 |
| 52 | behavioral response to ethanol (GO:0048149) | 3.31105066 |
| 53 | * sensory perception of light stimulus (GO:0050953) | 3.28451491 |
| 54 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.24924941 |
| 55 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.24776027 |
| 56 | tryptophan metabolic process (GO:0006568) | 3.24291772 |
| 57 | keratan sulfate catabolic process (GO:0042340) | 3.24269240 |
| 58 | auditory receptor cell stereocilium organization (GO:0060088) | 3.21153547 |
| 59 | regulation of plasminogen activation (GO:0010755) | 3.18528192 |
| 60 | indole-containing compound metabolic process (GO:0042430) | 3.17462070 |
| 61 | acrosome assembly (GO:0001675) | 3.16850293 |
| 62 | inner ear receptor cell development (GO:0060119) | 3.16121843 |
| 63 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.14981312 |
| 64 | response to pheromone (GO:0019236) | 3.12357251 |
| 65 | cellular hormone metabolic process (GO:0034754) | 3.12347860 |
| 66 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.09555964 |
| 67 | pigment biosynthetic process (GO:0046148) | 3.07380457 |
| 68 | white fat cell differentiation (GO:0050872) | 3.06698527 |
| 69 | behavioral defense response (GO:0002209) | 3.05710366 |
| 70 | behavioral fear response (GO:0001662) | 3.05710366 |
| 71 | reflex (GO:0060004) | 3.05419470 |
| 72 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.01678827 |
| 73 | platelet dense granule organization (GO:0060155) | 3.01214949 |
| 74 | postsynaptic membrane organization (GO:0001941) | 3.00316538 |
| 75 | regulation of skeletal muscle contraction (GO:0014819) | 2.97006442 |
| 76 | developmental pigmentation (GO:0048066) | 2.94827015 |
| 77 | aromatic amino acid family metabolic process (GO:0009072) | 2.93807844 |
| 78 | terpenoid biosynthetic process (GO:0016114) | 2.93479485 |
| 79 | icosanoid secretion (GO:0032309) | 2.92437894 |
| 80 | arachidonic acid secretion (GO:0050482) | 2.92437894 |
| 81 | retinal cone cell development (GO:0046549) | 2.90521847 |
| 82 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.90503365 |
| 83 | mitochondrial RNA metabolic process (GO:0000959) | 2.90421719 |
| 84 | * detection of external stimulus (GO:0009581) | 2.90412387 |
| 85 | regulation of sarcomere organization (GO:0060297) | 2.86949426 |
| 86 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.84553758 |
| 87 | righting reflex (GO:0060013) | 2.84452205 |
| 88 | * detection of abiotic stimulus (GO:0009582) | 2.82229876 |
| 89 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.79749773 |
| 90 | photoreceptor cell development (GO:0042461) | 2.79696895 |
| 91 | eye photoreceptor cell differentiation (GO:0001754) | 2.75173399 |
| 92 | photoreceptor cell differentiation (GO:0046530) | 2.75173399 |
| 93 | positive regulation of neuroblast proliferation (GO:0002052) | 2.74427488 |
| 94 | regulation of gonadotropin secretion (GO:0032276) | 2.74310921 |
| 95 | embryonic viscerocranium morphogenesis (GO:0048703) | 2.73514300 |
| 96 | fear response (GO:0042596) | 2.72946977 |
| 97 | negative regulation of stress fiber assembly (GO:0051497) | 2.71665075 |
| 98 | axoneme assembly (GO:0035082) | 2.71129013 |
| 99 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.70561475 |
| 100 | organic cation transport (GO:0015695) | 2.70401180 |
| 101 | adult feeding behavior (GO:0008343) | 2.70113685 |
| 102 | cellular ketone body metabolic process (GO:0046950) | 2.68004108 |
| 103 | inner ear receptor stereocilium organization (GO:0060122) | 2.67471344 |
| 104 | fucose catabolic process (GO:0019317) | 2.67326078 |
| 105 | L-fucose metabolic process (GO:0042354) | 2.67326078 |
| 106 | L-fucose catabolic process (GO:0042355) | 2.67326078 |
| 107 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.65358020 |
| 108 | neuroepithelial cell differentiation (GO:0060563) | 2.64696932 |
| 109 | eye photoreceptor cell development (GO:0042462) | 2.64399171 |
| 110 | neuronal action potential propagation (GO:0019227) | 2.62572176 |
| 111 | regulation of guanylate cyclase activity (GO:0031282) | 2.62119702 |
| 112 | neural tube formation (GO:0001841) | 2.61766652 |
| 113 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 2.61714642 |
| 114 | regulation of sequestering of triglyceride (GO:0010889) | 2.58675143 |
| 115 | cellular biogenic amine catabolic process (GO:0042402) | 2.54204356 |
| 116 | amine catabolic process (GO:0009310) | 2.54204356 |
| 117 | heme transport (GO:0015886) | 2.52455684 |
| 118 | piRNA metabolic process (GO:0034587) | 2.52428950 |
| 119 | icosanoid transport (GO:0071715) | 2.51014627 |
| 120 | fatty acid derivative transport (GO:1901571) | 2.51014627 |
| 121 | innervation (GO:0060384) | 2.50233250 |
| 122 | cornea development in camera-type eye (GO:0061303) | 2.47458181 |
| 123 | sulfur amino acid biosynthetic process (GO:0000097) | 2.46972795 |
| 124 | establishment of protein localization to Golgi (GO:0072600) | 2.46870794 |
| 125 | protein-cofactor linkage (GO:0018065) | 2.46169807 |
| 126 | nonmotile primary cilium assembly (GO:0035058) | 2.45990292 |
| 127 | benzene-containing compound metabolic process (GO:0042537) | 2.42631769 |
| 128 | amino acid salvage (GO:0043102) | 2.42423651 |
| 129 | L-methionine salvage (GO:0071267) | 2.42423651 |
| 130 | L-methionine biosynthetic process (GO:0071265) | 2.42423651 |
| 131 | C4-dicarboxylate transport (GO:0015740) | 2.42347632 |
| 132 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.41012131 |
| 133 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.40786291 |
| 134 | regulation of action potential (GO:0098900) | 2.40397882 |
| 135 | pigment metabolic process (GO:0042440) | 2.37667399 |
| 136 | negative regulation of hormone metabolic process (GO:0032351) | 2.36448899 |
| 137 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.36448899 |
| 138 | eye morphogenesis (GO:0048592) | 2.35971804 |
| 139 | short-chain fatty acid metabolic process (GO:0046459) | 2.31981694 |
| 140 | somatic stem cell division (GO:0048103) | 2.30093614 |
| 141 | skeletal muscle adaptation (GO:0043501) | 2.28936135 |
| 142 | organ formation (GO:0048645) | 2.27702129 |
| 143 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.27041122 |
| 144 | branch elongation of an epithelium (GO:0060602) | 2.26751426 |
| 145 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.23504000 |
| 146 | regulation of systemic arterial blood pressure (GO:0003073) | 2.16723327 |
| 147 | myelination in peripheral nervous system (GO:0022011) | 2.15272373 |
| 148 | peripheral nervous system axon ensheathment (GO:0032292) | 2.15272373 |
| 149 | * protein-chromophore linkage (GO:0018298) | 2.13369388 |
| 150 | leukotriene biosynthetic process (GO:0019370) | 2.11109554 |
| 151 | axis elongation (GO:0003401) | 2.07733817 |
| 152 | vitamin metabolic process (GO:0006766) | 2.06204579 |
| 153 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.05379641 |
| 154 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.04826156 |
| 155 | mitochondrion localization (GO:0051646) | 2.04275344 |
| 156 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.03593690 |
| 157 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.03137279 |
| 158 | collagen metabolic process (GO:0032963) | 2.02394555 |
| 159 | collagen catabolic process (GO:0030574) | 2.01267639 |
| 160 | regulation of neuroblast proliferation (GO:1902692) | 2.00255522 |
| 161 | melanin biosynthetic process (GO:0042438) | 14.9323343 |
| 162 | retinal metabolic process (GO:0042574) | 13.9205199 |
| 163 | melanin metabolic process (GO:0006582) | 13.5327676 |
| 164 | secondary metabolite biosynthetic process (GO:0044550) | 12.6091895 |
| 165 | retinol metabolic process (GO:0042572) | 10.7943951 |
| 166 | cellular response to electrical stimulus (GO:0071257) | 10.4265322 |
| 167 | multicellular organismal macromolecule metabolic process (GO:0044259) | 1.93586073 |
| 168 | rhodopsin mediated signaling pathway (GO:0016056) | 1.91231906 |
| 169 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 1.87188645 |
| 170 | endothelial cell morphogenesis (GO:0001886) | 1.85970693 |
| 171 | multicellular organismal catabolic process (GO:0044243) | 1.85080078 |
| 172 | tonic smooth muscle contraction (GO:0014820) | 1.84605199 |
| 173 | L-ascorbic acid metabolic process (GO:0019852) | 1.83243451 |
| 174 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 1.82502056 |
| 175 | multicellular organismal metabolic process (GO:0044236) | 1.82264417 |
| 176 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 1.81889910 |
| 177 | phenol-containing compound metabolic process (GO:0018958) | 1.81326408 |
| 178 | positive regulation of cell junction assembly (GO:1901890) | 1.77877440 |
| 179 | positive regulation of focal adhesion assembly (GO:0051894) | 1.77877440 |
| 180 | neuronal ion channel clustering (GO:0045161) | 1.76213044 |
| 181 | pyruvate metabolic process (GO:0006090) | 1.74103955 |
| 182 | monocarboxylic acid transport (GO:0015718) | 1.73543001 |
| 183 | hormone metabolic process (GO:0042445) | 1.72540561 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 5.05973176 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.34775292 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.31627379 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 3.23966173 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.78868583 |
| 6 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.72106761 |
| 7 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.69450568 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.63413339 |
| 9 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.53279925 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.51002636 |
| 11 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.29684939 |
| 12 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.25309099 |
| 13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.23484758 |
| 14 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 2.20433097 |
| 15 | P300_19829295_ChIP-Seq_ESCs_Human | 2.16114942 |
| 16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.06583964 |
| 17 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.04330885 |
| 18 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.99426401 |
| 19 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.97987377 |
| 20 | FUS_26573619_Chip-Seq_HEK293_Human | 1.97821571 |
| 21 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.96492998 |
| 22 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.91994402 |
| 23 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.91165773 |
| 24 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.88934700 |
| 25 | EWS_26573619_Chip-Seq_HEK293_Human | 1.87536271 |
| 26 | STAT3_23295773_ChIP-Seq_U87_Human | 1.85361084 |
| 27 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.78183980 |
| 28 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.76954394 |
| 29 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.74133438 |
| 30 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.71449199 |
| 31 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.68399724 |
| 32 | TCF4_23295773_ChIP-Seq_U87_Human | 1.66055244 |
| 33 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.66048897 |
| 34 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.63184689 |
| 35 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60792852 |
| 36 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.60467050 |
| 37 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.60135225 |
| 38 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.57393646 |
| 39 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.57393646 |
| 40 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.57187846 |
| 41 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.56425750 |
| 42 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.56180012 |
| 43 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.55670229 |
| 44 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.54141281 |
| 45 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.54069535 |
| 46 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.52933811 |
| 47 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.52538833 |
| 48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.51666032 |
| 49 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.51554755 |
| 50 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.51554755 |
| 51 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.50389398 |
| 52 | CJUN_26792858_Chip-Seq_BT549_Human | 1.49593290 |
| 53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.48887259 |
| 54 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.47942500 |
| 55 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.47330686 |
| 56 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.45927413 |
| 57 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.44767507 |
| 58 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.44225062 |
| 59 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.43244469 |
| 60 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.42481089 |
| 61 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.40197403 |
| 62 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.38281615 |
| 63 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.37756817 |
| 64 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.35734875 |
| 65 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.34400873 |
| 66 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.33523675 |
| 67 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.33102140 |
| 68 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.32788034 |
| 69 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.32501019 |
| 70 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.32335438 |
| 71 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.31493560 |
| 72 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.30726659 |
| 73 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.30593707 |
| 74 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.30593707 |
| 75 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.30166371 |
| 76 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.30144757 |
| 77 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30144757 |
| 78 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.29709068 |
| 79 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.29373939 |
| 80 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.27932493 |
| 81 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27810137 |
| 82 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.27793080 |
| 83 | TP53_16413492_ChIP-PET_HCT116_Human | 1.25915715 |
| 84 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.25643718 |
| 85 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.24650043 |
| 86 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.24351993 |
| 87 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.24348982 |
| 88 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.24068101 |
| 89 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.23836339 |
| 90 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.23689254 |
| 91 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.23444818 |
| 92 | AR_25329375_ChIP-Seq_VCAP_Human | 1.23346795 |
| 93 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.23214569 |
| 94 | KDM2B_26808549_Chip-Seq_REH_Human | 1.23018669 |
| 95 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.22272254 |
| 96 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.21605266 |
| 97 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.21563410 |
| 98 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.21213059 |
| 99 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.20620195 |
| 100 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.20529389 |
| 101 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.20478594 |
| 102 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.18405170 |
| 103 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.17891537 |
| 104 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.17426144 |
| 105 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.17136851 |
| 106 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.17056361 |
| 107 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.16974571 |
| 108 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16868714 |
| 109 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.16622427 |
| 110 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.16401098 |
| 111 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.16156476 |
| 112 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.15869208 |
| 113 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.15775217 |
| 114 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.14882626 |
| 115 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.14812624 |
| 116 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.14402810 |
| 117 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.14017891 |
| 118 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.13945023 |
| 119 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.13944021 |
| 120 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12890572 |
| 121 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.12756812 |
| 122 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.12478872 |
| 123 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.10818723 |
| 124 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.10818723 |
| 125 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.10303302 |
| 126 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.09221586 |
| 127 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09000050 |
| 128 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.08745623 |
| 129 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.08073188 |
| 130 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.07771914 |
| 131 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07713967 |
| 132 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06987905 |
| 133 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.06855269 |
| 134 | NCOR_22424771_ChIP-Seq_293T_Human | 1.06785817 |
| 135 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06441104 |
| 136 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.05885902 |
| 137 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.05577320 |
| 138 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.05510377 |
| 139 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04501095 |
| 140 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04114731 |
| 141 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.03899116 |
| 142 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.03501592 |
| 143 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.02445238 |
| 144 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.02381412 |
| 145 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.02063284 |
| 146 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00868708 |
| 147 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99828708 |
| 148 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.99529972 |
| 149 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.99175966 |
| 150 | RXR_22108803_ChIP-Seq_LS180_Human | 0.98941531 |
| 151 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98770739 |
| 152 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98683737 |
| 153 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.97855785 |
| 154 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.97855785 |
| 155 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96606263 |
| 156 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96559924 |
| 157 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.96502051 |
| 158 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96146048 |
| 159 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96077317 |
| 160 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.95416038 |
| 161 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.95041472 |
| 162 | TBL1_22424771_ChIP-Seq_293T_Human | 0.95005586 |
| 163 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.94761585 |
| 164 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.93090651 |
| 165 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92600384 |
| 166 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.91469603 |
| 167 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.91143741 |
| 168 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90711503 |
| 169 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.90588003 |
| 170 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.89564545 |
| 171 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89365716 |
| 172 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.89100441 |
| 173 | KDM2B_26808549_Chip-Seq_K562_Human | 0.88418394 |
| 174 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.87775178 |
| 175 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.87408109 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000372_irregular_coat_pigmentation | 5.08329238 |
| 2 | MP0005257_abnormal_intraocular_pressure | 4.95511119 |
| 3 | MP0003136_yellow_coat_color | 4.03891419 |
| 4 | MP0004019_abnormal_vitamin_homeostasis | 3.72549635 |
| 5 | MP0005171_absent_coat_pigmentation | 3.63678743 |
| 6 | MP0001324_abnormal_eye_pigmentation | 3.18520093 |
| 7 | MP0005646_abnormal_pituitary_gland | 3.17455846 |
| 8 | MP0002736_abnormal_nociception_after | 2.96158349 |
| 9 | MP0001986_abnormal_taste_sensitivity | 2.95801834 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.84323878 |
| 11 | * MP0005551_abnormal_eye_electrophysiolog | 2.73083821 |
| 12 | MP0002090_abnormal_vision | 2.72683097 |
| 13 | * MP0005253_abnormal_eye_physiology | 2.39889159 |
| 14 | MP0004147_increased_porphyrin_level | 2.38831207 |
| 15 | MP0005670_abnormal_white_adipose | 2.34403042 |
| 16 | MP0005408_hypopigmentation | 2.28818423 |
| 17 | MP0000371_diluted_coat_color | 2.27636496 |
| 18 | MP0005423_abnormal_somatic_nervous | 2.19101876 |
| 19 | MP0005409_darkened_coat_color | 2.03946875 |
| 20 | MP0003011_delayed_dark_adaptation | 15.9105995 |
| 21 | MP0003880_abnormal_central_pattern | 1.92386082 |
| 22 | MP0001486_abnormal_startle_reflex | 1.83492882 |
| 23 | MP0009046_muscle_twitch | 1.70948591 |
| 24 | MP0001501_abnormal_sleep_pattern | 1.69654277 |
| 25 | MP0003195_calcinosis | 1.68593404 |
| 26 | MP0000015_abnormal_ear_pigmentation | 1.66983129 |
| 27 | MP0009745_abnormal_behavioral_response | 1.64640040 |
| 28 | MP0003183_abnormal_peptide_metabolism | 1.63983541 |
| 29 | MP0002735_abnormal_chemical_nociception | 1.58660298 |
| 30 | MP0008995_early_reproductive_senescence | 1.57977394 |
| 31 | MP0006276_abnormal_autonomic_nervous | 1.55142861 |
| 32 | MP0002272_abnormal_nervous_system | 1.53848798 |
| 33 | MP0008872_abnormal_physiological_respon | 1.52056708 |
| 34 | MP0001764_abnormal_homeostasis | 1.45098688 |
| 35 | * MP0005391_vision/eye_phenotype | 1.42182906 |
| 36 | MP0005075_abnormal_melanosome_morpholog | 1.41879240 |
| 37 | MP0008438_abnormal_cutaneous_collagen | 1.40253945 |
| 38 | MP0000631_abnormal_neuroendocrine_gland | 1.36158150 |
| 39 | MP0002092_abnormal_eye_morphology | 1.34732716 |
| 40 | MP0002075_abnormal_coat/hair_pigmentati | 1.34711905 |
| 41 | MP0004381_abnormal_hair_follicle | 1.32851739 |
| 42 | MP0000516_abnormal_urinary_system | 1.31873325 |
| 43 | MP0005367_renal/urinary_system_phenotyp | 1.31873325 |
| 44 | MP0001485_abnormal_pinna_reflex | 1.30417622 |
| 45 | MP0002876_abnormal_thyroid_physiology | 1.24892612 |
| 46 | MP0001984_abnormal_olfaction | 1.22259237 |
| 47 | MP0002064_seizures | 1.20212039 |
| 48 | MP0003646_muscle_fatigue | 1.20062155 |
| 49 | MP0002572_abnormal_emotion/affect_behav | 1.18019178 |
| 50 | MP0005503_abnormal_tendon_morphology | 1.16469244 |
| 51 | MP0005197_abnormal_uvea_morphology | 1.15926257 |
| 52 | MP0005195_abnormal_posterior_eye | 1.15208920 |
| 53 | MP0003635_abnormal_synaptic_transmissio | 1.14340409 |
| 54 | MP0002095_abnormal_skin_pigmentation | 1.14129455 |
| 55 | MP0005275_abnormal_skin_tensile | 1.11386530 |
| 56 | MP0002138_abnormal_hepatobiliary_system | 1.10385932 |
| 57 | MP0001970_abnormal_pain_threshold | 1.08204800 |
| 58 | MP0001186_pigmentation_phenotype | 1.07473822 |
| 59 | MP0002063_abnormal_learning/memory/cond | 1.07094910 |
| 60 | MP0002877_abnormal_melanocyte_morpholog | 1.07030183 |
| 61 | MP0002733_abnormal_thermal_nociception | 1.04899797 |
| 62 | MP0000026_abnormal_inner_ear | 1.04384242 |
| 63 | MP0004133_heterotaxia | 1.03227876 |
| 64 | MP0004885_abnormal_endolymph | 1.02262513 |
| 65 | MP0001963_abnormal_hearing_physiology | 1.01804690 |
| 66 | MP0005174_abnormal_tail_pigmentation | 1.01087366 |
| 67 | MP0004142_abnormal_muscle_tone | 0.99641787 |
| 68 | MP0002067_abnormal_sensory_capabilities | 0.98990209 |
| 69 | MP0002234_abnormal_pharynx_morphology | 0.98054051 |
| 70 | MP0003633_abnormal_nervous_system | 0.96540015 |
| 71 | MP0003878_abnormal_ear_physiology | 0.91777185 |
| 72 | MP0005377_hearing/vestibular/ear_phenot | 0.91777185 |
| 73 | MP0008877_abnormal_DNA_methylation | 0.91080102 |
| 74 | MP0004272_abnormal_basement_membrane | 0.87114972 |
| 75 | MP0002089_abnormal_postnatal_growth/wei | 0.85880390 |
| 76 | MP0004742_abnormal_vestibular_system | 0.85401415 |
| 77 | MP0005410_abnormal_fertilization | 0.84148551 |
| 78 | MP0001661_extended_life_span | 0.83330860 |
| 79 | MP0002557_abnormal_social/conspecific_i | 0.81558867 |
| 80 | MP0002734_abnormal_mechanical_nocicepti | 0.80710178 |
| 81 | MP0005193_abnormal_anterior_eye | 0.80472926 |
| 82 | MP0003705_abnormal_hypodermis_morpholog | 0.77820542 |
| 83 | MP0005332_abnormal_amino_acid | 0.77199528 |
| 84 | MP0003045_fibrosis | 0.76178475 |
| 85 | MP0005386_behavior/neurological_phenoty | 0.75415367 |
| 86 | MP0004924_abnormal_behavior | 0.75415367 |
| 87 | MP0001502_abnormal_circadian_rhythm | 0.75010096 |
| 88 | MP0000230_abnormal_systemic_arterial | 0.74655314 |
| 89 | MP0010386_abnormal_urinary_bladder | 0.74177848 |
| 90 | MP0006292_abnormal_olfactory_placode | 0.72943050 |
| 91 | MP0001756_abnormal_urination | 0.71395017 |
| 92 | MP0000427_abnormal_hair_cycle | 0.71312997 |
| 93 | MP0002184_abnormal_innervation | 0.71192494 |
| 94 | MP0004043_abnormal_pH_regulation | 0.70673876 |
| 95 | MP0005647_abnormal_sex_gland | 0.69303199 |
| 96 | MP0003698_abnormal_male_reproductive | 0.68181495 |
| 97 | MP0000647_abnormal_sebaceous_gland | 0.65893467 |
| 98 | MP0000778_abnormal_nervous_system | 0.65391962 |
| 99 | MP0006054_spinal_hemorrhage | 0.65004405 |
| 100 | MP0005645_abnormal_hypothalamus_physiol | 0.64909104 |
| 101 | MP0003724_increased_susceptibility_to | 0.63539617 |
| 102 | MP0003879_abnormal_hair_cell | 0.62598069 |
| 103 | MP0010234_abnormal_vibrissa_follicle | 0.61903332 |
| 104 | MP0003631_nervous_system_phenotype | 0.61605358 |
| 105 | MP0010329_abnormal_lipoprotein_level | 0.58382117 |
| 106 | MP0009384_cardiac_valve_regurgitation | 0.53094010 |
| 107 | MP0004084_abnormal_cardiac_muscle | 0.52802003 |
| 108 | MP0002229_neurodegeneration | 0.52307156 |
| 109 | MP0010368_abnormal_lymphatic_system | 0.50639707 |
| 110 | MP0004036_abnormal_muscle_relaxation | 0.49977475 |
| 111 | MP0002638_abnormal_pupillary_reflex | 0.49880100 |
| 112 | MP0002102_abnormal_ear_morphology | 0.48226532 |
| 113 | MP0002139_abnormal_hepatobiliary_system | 0.47753951 |
| 114 | MP0005248_abnormal_Harderian_gland | 0.46083304 |
| 115 | MP0004130_abnormal_muscle_cell | 0.42481981 |
| 116 | MP0002752_abnormal_somatic_nervous | 0.41657904 |
| 117 | MP0002938_white_spotting | 0.40197311 |
| 118 | MP0005360_urolithiasis | 0.35992240 |
| 119 | MP0005167_abnormal_blood-brain_barrier | 0.34906635 |
| 120 | MP0000751_myopathy | 0.31625932 |
| 121 | MP0002108_abnormal_muscle_morphology | 0.31022241 |
| 122 | MP0008875_abnormal_xenobiotic_pharmacok | 0.30310898 |
| 123 | MP0000013_abnormal_adipose_tissue | 0.28529013 |
| 124 | MP0000367_abnormal_coat/_hair | 0.26891694 |
| 125 | MP0003453_abnormal_keratinocyte_physiol | 0.26573416 |
| 126 | MP0000428_abnormal_craniofacial_morphol | 0.26486948 |
| 127 | MP0005085_abnormal_gallbladder_physiolo | 0.26169932 |
| 128 | MP0004270_analgesia | 0.25864114 |
| 129 | MP0009780_abnormal_chondrocyte_physiolo | 0.25854148 |
| 130 | MP0010030_abnormal_orbit_morphology | 0.24569774 |
| 131 | MP0002177_abnormal_outer_ear | 0.24515689 |
| 132 | MP0003690_abnormal_glial_cell | 0.24268683 |
| 133 | MP0002233_abnormal_nose_morphology | 0.24088555 |
| 134 | MP0009840_abnormal_foam_cell | 0.24080110 |
| 135 | MP0002882_abnormal_neuron_morphology | 0.23607392 |
| 136 | MP0006072_abnormal_retinal_apoptosis | 0.23579120 |
| 137 | MP0005623_abnormal_meninges_morphology | 0.23491801 |
| 138 | MP0000747_muscle_weakness | 0.23054371 |
| 139 | MP0003941_abnormal_skin_development | 0.22994178 |
| 140 | MP0003300_gastrointestinal_ulcer | 0.22970730 |
| 141 | MP0003938_abnormal_ear_development | 0.22615044 |
| 142 | MP0005620_abnormal_muscle_contractility | 0.21695562 |
| 143 | MP0004859_abnormal_synaptic_plasticity | 0.19893034 |
| 144 | MP0002332_abnormal_exercise_endurance | 0.19762845 |
| 145 | MP0000569_abnormal_digit_pigmentation | 0.18798879 |
| 146 | MP0003279_aneurysm | 0.17629742 |
| 147 | MP0008775_abnormal_heart_ventricle | 0.17502014 |
| 148 | MP0003329_amyloid_beta_deposits | 0.16130047 |
| 149 | MP0005365_abnormal_bile_salt | 0.15977416 |
| 150 | MP0004145_abnormal_muscle_electrophysio | 0.15818185 |
| 151 | MP0003806_abnormal_nucleotide_metabolis | 0.15749580 |
| 152 | MP0005508_abnormal_skeleton_morphology | 0.15395098 |
| 153 | MP0003075_altered_response_to | 0.15066264 |
| 154 | MP0003252_abnormal_bile_duct | 0.13749893 |
| 155 | MP0001958_emphysema | 0.13716152 |
| 156 | MP0001879_abnormal_lymphatic_vessel | 0.13686308 |
| 157 | MP0003115_abnormal_respiratory_system | 0.13273847 |
| 158 | MP0002837_dystrophic_cardiac_calcinosis | 0.12750571 |
| 159 | MP0000467_abnormal_esophagus_morphology | 0.12636160 |
| 160 | MP0000749_muscle_degeneration | 0.12413553 |
| 161 | MP0010678_abnormal_skin_adnexa | 0.12333245 |
| 162 | MP0004215_abnormal_myocardial_fiber | 0.12044797 |
| 163 | MP0003566_abnormal_cell_adhesion | 0.11834549 |
| 164 | MP0001177_atelectasis | 0.11512601 |
| 165 | MP0005187_abnormal_penis_morphology | 0.11464017 |
| 166 | MP0002282_abnormal_trachea_morphology | 0.10796832 |
| 167 | MP0002118_abnormal_lipid_homeostasis | 0.10476651 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased corneal curvature (HP:0100692) | 8.46025954 |
| 2 | Keratoconus (HP:0000563) | 8.46025954 |
| 3 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 8.20767965 |
| 4 | Hypoplasia of the fovea (HP:0007750) | 8.20767965 |
| 5 | * Attenuation of retinal blood vessels (HP:0007843) | 7.57950007 |
| 6 | * Hypopigmentation of the fundus (HP:0007894) | 6.93760856 |
| 7 | Choroideremia (HP:0001139) | 6.60608120 |
| 8 | Aplasia/Hypoplasia of the macula (HP:0008059) | 6.44420454 |
| 9 | Bony spicule pigmentary retinopathy (HP:0007737) | 6.13156920 |
| 10 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 6.04440806 |
| 11 | Blue irides (HP:0000635) | 5.86753074 |
| 12 | Abnormal rod and cone electroretinograms (HP:0008323) | 5.64943817 |
| 13 | Abolished electroretinogram (ERG) (HP:0000550) | 5.51859692 |
| 14 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 5.19711836 |
| 15 | Abnormality of alanine metabolism (HP:0010916) | 5.19711836 |
| 16 | Hyperalaninemia (HP:0003348) | 5.19711836 |
| 17 | Scotoma (HP:0000575) | 4.85283922 |
| 18 | Nonprogressive disorder (HP:0003680) | 4.84831660 |
| 19 | Congenital sensorineural hearing impairment (HP:0008527) | 4.84404393 |
| 20 | Action tremor (HP:0002345) | 4.31808626 |
| 21 | Ocular albinism (HP:0001107) | 4.20499855 |
| 22 | Iris hypopigmentation (HP:0007730) | 3.75284935 |
| 23 | Congenital stationary night blindness (HP:0007642) | 3.70693184 |
| 24 | Pendular nystagmus (HP:0012043) | 3.66624379 |
| 25 | Pancreatic cysts (HP:0001737) | 3.46710272 |
| 26 | Corneal dystrophy (HP:0001131) | 3.40883429 |
| 27 | True hermaphroditism (HP:0010459) | 3.39782838 |
| 28 | Pancreatic fibrosis (HP:0100732) | 3.23208082 |
| 29 | Hyperventilation (HP:0002883) | 3.17925557 |
| 30 | * Type II diabetes mellitus (HP:0005978) | 3.12200523 |
| 31 | Chronic hepatic failure (HP:0100626) | 3.12020242 |
| 32 | Progressive cerebellar ataxia (HP:0002073) | 2.93975974 |
| 33 | Macular degeneration (HP:0000608) | 2.92927212 |
| 34 | Abnormality of midbrain morphology (HP:0002418) | 2.91275602 |
| 35 | Molar tooth sign on MRI (HP:0002419) | 2.91275602 |
| 36 | Gaze-evoked nystagmus (HP:0000640) | 2.85132947 |
| 37 | * Photophobia (HP:0000613) | 2.84114901 |
| 38 | * Constricted visual fields (HP:0001133) | 2.81251134 |
| 39 | Intestinal atresia (HP:0011100) | 2.70920440 |
| 40 | Generalized hypopigmentation of hair (HP:0011358) | 2.63682240 |
| 41 | Thyroid-stimulating hormone excess (HP:0002925) | 2.58494210 |
| 42 | Nephronophthisis (HP:0000090) | 2.58233720 |
| 43 | Freckling (HP:0001480) | 2.54192614 |
| 44 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.53691690 |
| 45 | Stereotypic behavior (HP:0000733) | 2.49334253 |
| 46 | Central scotoma (HP:0000603) | 2.48382527 |
| 47 | Absent speech (HP:0001344) | 2.46948192 |
| 48 | Pigmentary retinal degeneration (HP:0001146) | 2.34271479 |
| 49 | Abnormality of the renal cortex (HP:0011035) | 2.34248385 |
| 50 | Febrile seizures (HP:0002373) | 2.32319036 |
| 51 | Abnormality of the renal medulla (HP:0100957) | 2.31904134 |
| 52 | Ulnar claw (HP:0001178) | 2.29968597 |
| 53 | Medial flaring of the eyebrow (HP:0010747) | 2.29166820 |
| 54 | Type 1 muscle fiber predominance (HP:0003803) | 2.28968242 |
| 55 | Genetic anticipation (HP:0003743) | 2.27152246 |
| 56 | Protrusio acetabuli (HP:0003179) | 2.25833369 |
| 57 | Chorioretinal atrophy (HP:0000533) | 2.23741266 |
| 58 | Focal seizures (HP:0007359) | 2.22596982 |
| 59 | Broad-based gait (HP:0002136) | 2.22191661 |
| 60 | Exercise-induced muscle cramps (HP:0003710) | 2.21807278 |
| 61 | Severe visual impairment (HP:0001141) | 2.21759116 |
| 62 | Focal motor seizures (HP:0011153) | 2.21470679 |
| 63 | Progressive inability to walk (HP:0002505) | 2.21303501 |
| 64 | Cystic liver disease (HP:0006706) | 2.20276201 |
| 65 | Inability to walk (HP:0002540) | 2.15371496 |
| 66 | Spontaneous hematomas (HP:0007420) | 2.14117555 |
| 67 | Abnormality of the labia minora (HP:0012880) | 2.09636666 |
| 68 | Abnormality of serum amino acid levels (HP:0003112) | 2.06863982 |
| 69 | Blindness (HP:0000618) | 2.05871899 |
| 70 | Hemiparesis (HP:0001269) | 2.04964868 |
| 71 | Hyperglycinemia (HP:0002154) | 2.03331729 |
| 72 | Dyschromatopsia (HP:0007641) | 2.01095938 |
| 73 | Anencephaly (HP:0002323) | 2.00486184 |
| 74 | Type II lissencephaly (HP:0007260) | 2.00181473 |
| 75 | * Decreased electroretinogram (ERG) amplitude (HP:0000654) | 13.8148906 |
| 76 | Abnormality of the fovea (HP:0000493) | 11.6583012 |
| 77 | Decreased central vision (HP:0007663) | 10.7113981 |
| 78 | Atonic seizures (HP:0010819) | 1.98242131 |
| 79 | Nephrogenic diabetes insipidus (HP:0009806) | 1.97436181 |
| 80 | Dialeptic seizures (HP:0011146) | 1.96033522 |
| 81 | Gait imbalance (HP:0002141) | 1.93612088 |
| 82 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.88053337 |
| 83 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.87682255 |
| 84 | Round ear (HP:0100830) | 1.87449131 |
| 85 | Renal cortical cysts (HP:0000803) | 1.87240061 |
| 86 | Abnormal drinking behavior (HP:0030082) | 1.86375889 |
| 87 | Polydipsia (HP:0001959) | 1.86375889 |
| 88 | Esophageal varix (HP:0002040) | 1.85549115 |
| 89 | Epidermoid cyst (HP:0200040) | 1.84851915 |
| 90 | Poor speech (HP:0002465) | 1.83825606 |
| 91 | Postural tremor (HP:0002174) | 1.83337273 |
| 92 | Congenital primary aphakia (HP:0007707) | 1.83094891 |
| 93 | Generalized hypopigmentation (HP:0007513) | 1.80790749 |
| 94 | Birth length less than 3rd percentile (HP:0003561) | 1.80152103 |
| 95 | Abnormality of macular pigmentation (HP:0008002) | 1.79519313 |
| 96 | Hyperglycinuria (HP:0003108) | 1.79017739 |
| 97 | White forelock (HP:0002211) | 1.78878247 |
| 98 | Genital tract atresia (HP:0001827) | 1.76990162 |
| 99 | Short tibia (HP:0005736) | 1.72562352 |
| 100 | Abnormality of the renal collecting system (HP:0004742) | 1.69926013 |
| 101 | Bile duct proliferation (HP:0001408) | 1.67951429 |
| 102 | Abnormal biliary tract physiology (HP:0012439) | 1.67951429 |
| 103 | Absence seizures (HP:0002121) | 1.67435449 |
| 104 | Tubular atrophy (HP:0000092) | 1.65525633 |
| 105 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.65092222 |
| 106 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.65092222 |
| 107 | Aortic dissection (HP:0002647) | 1.64711961 |
| 108 | Postaxial foot polydactyly (HP:0001830) | 1.64186605 |
| 109 | Hypomagnesemia (HP:0002917) | 1.63629640 |
| 110 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.63459890 |
| 111 | Abnormality of glycine metabolism (HP:0010895) | 1.63459890 |
| 112 | Distal arthrogryposis (HP:0005684) | 1.63380011 |
| 113 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.63364788 |
| 114 | Nemaline bodies (HP:0003798) | 1.62624972 |
| 115 | Vaginal atresia (HP:0000148) | 1.62488722 |
| 116 | Tubulointerstitial nephritis (HP:0001970) | 1.61486412 |
| 117 | Sclerocornea (HP:0000647) | 1.59895029 |
| 118 | Cerebral aneurysm (HP:0004944) | 1.59084928 |
| 119 | Broad metatarsal (HP:0001783) | 1.58859137 |
| 120 | Hypoplasia of the iris (HP:0007676) | 1.57621485 |
| 121 | Muscle fiber inclusion bodies (HP:0100299) | 1.57505995 |
| 122 | Hypermetropia (HP:0000540) | 1.55490884 |
| 123 | Aortic aneurysm (HP:0004942) | 1.53414083 |
| 124 | Patchy hypopigmentation of hair (HP:0011365) | 1.50436872 |
| 125 | Flat cornea (HP:0007720) | 1.50436676 |
| 126 | Right ventricular cardiomyopathy (HP:0011663) | 1.48564774 |
| 127 | Subacute progressive viral hepatitis (HP:0006572) | 1.46072221 |
| 128 | * Wide nasal bridge (HP:0000431) | 1.45322355 |
| 129 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.41987366 |
| 130 | Cone-rod dystrophy (HP:0000548) | 1.41572294 |
| 131 | Annular pancreas (HP:0001734) | 1.38838555 |
| 132 | Exercise-induced myalgia (HP:0003738) | 1.36615015 |
| 133 | Deep venous thrombosis (HP:0002625) | 1.35625643 |
| 134 | Premature rupture of membranes (HP:0001788) | 1.34275375 |
| 135 | Heterochromia iridis (HP:0001100) | 1.34085257 |
| 136 | Mitral valve prolapse (HP:0001634) | 1.32799070 |
| 137 | Calcaneovalgus deformity (HP:0001848) | 1.32777456 |
| 138 | Xanthomatosis (HP:0000991) | 1.32154243 |
| 139 | Hypoventilation (HP:0002791) | 1.29668118 |
| 140 | Arterial tortuosity (HP:0005116) | 1.29482105 |
| 141 | Slender build (HP:0001533) | 1.28020119 |
| 142 | Hypoalphalipoproteinemia (HP:0003233) | 1.27846323 |
| 143 | Increased connective tissue (HP:0009025) | 1.26989583 |
| 144 | Optic disc pallor (HP:0000543) | 1.26762046 |
| 145 | Hyperlipoproteinemia (HP:0010980) | 1.26048208 |
| 146 | Increased variability in muscle fiber diameter (HP:0003557) | 1.25634560 |
| 147 | Vascular tortuosity (HP:0004948) | 1.25024630 |
| 148 | Posterior subcapsular cataract (HP:0007787) | 1.24290561 |
| 149 | Retinitis pigmentosa (HP:0000510) | 1.23992864 |
| 150 | Subcapsular cataract (HP:0000523) | 1.18821440 |
| 151 | Pallor (HP:0000980) | 1.18332749 |
| 152 | Striae distensae (HP:0001065) | 1.16164093 |
| 153 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.14740122 |
| 154 | Deformed tarsal bones (HP:0008119) | 1.14572734 |
| 155 | Shallow orbits (HP:0000586) | 1.13563986 |
| 156 | Absent phalangeal crease (HP:0006109) | 1.13442855 |
| 157 | Hematochezia (HP:0002573) | 1.13358304 |
| 158 | Retinal atrophy (HP:0001105) | 1.12303512 |
| 159 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.11920769 |
| 160 | Frequent falls (HP:0002359) | 1.10461265 |
| 161 | Melanoma (HP:0002861) | 1.08985443 |
| 162 | Ulnar deviation of the wrist (HP:0003049) | 1.08252505 |
| 163 | EMG: myopathic abnormalities (HP:0003458) | 1.07144872 |
| 164 | Abnormality of vision evoked potentials (HP:0000649) | 1.05464130 |
| 165 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.04991025 |
| 166 | Vitreoretinal degeneration (HP:0000655) | 1.04215180 |
| 167 | Ankle contracture (HP:0006466) | 1.03659352 |
| 168 | Hypoglycemic coma (HP:0001325) | 1.02570082 |
| 169 | Hyporeflexia of lower limbs (HP:0002600) | 1.00130031 |
| 170 | Peritonitis (HP:0002586) | 0.99296444 |
| 171 | Progressive visual loss (HP:0000529) | 0.97107016 |
| 172 | Abnormal pancreas size (HP:0012094) | 0.96272598 |
| 173 | Mitral stenosis (HP:0001718) | 0.96176080 |
| 174 | Cardiovascular calcification (HP:0011915) | 0.95245023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 5.61567166 |
| 2 | MST1R | 4.40864179 |
| 3 | ACVR1B | 3.35502581 |
| 4 | PDK2 | 3.23404370 |
| 5 | ADRBK2 | 2.83202062 |
| 6 | PKN2 | 2.77120984 |
| 7 | TTN | 2.58588435 |
| 8 | TIE1 | 2.51844852 |
| 9 | LATS1 | 2.45673064 |
| 10 | DDR2 | 2.42985283 |
| 11 | FGFR2 | 2.32873900 |
| 12 | BMPR1B | 2.31166454 |
| 13 | WNK3 | 2.30607501 |
| 14 | TRIB3 | 2.25734298 |
| 15 | FRK | 2.20026207 |
| 16 | TGFBR2 | 2.16289461 |
| 17 | MET | 2.13137657 |
| 18 | CASK | 2.13101125 |
| 19 | MAPK13 | 1.88727174 |
| 20 | MAP4K2 | 1.88273717 |
| 21 | NUAK1 | 1.86284766 |
| 22 | RIPK1 | 1.77279332 |
| 23 | PTK6 | 1.76456065 |
| 24 | NTRK2 | 1.70250461 |
| 25 | MAP3K4 | 1.62047621 |
| 26 | SCYL2 | 1.59286703 |
| 27 | SIK1 | 1.55274998 |
| 28 | GRK1 | 1.53249281 |
| 29 | SGK2 | 1.50679278 |
| 30 | PDGFRA | 1.48347169 |
| 31 | LRRK2 | 1.44407469 |
| 32 | BMX | 1.44218648 |
| 33 | NTRK1 | 1.36583871 |
| 34 | PIK3CG | 1.30627999 |
| 35 | SGK223 | 1.29915112 |
| 36 | SGK494 | 1.29915112 |
| 37 | MAP3K2 | 1.28864529 |
| 38 | OXSR1 | 1.28352644 |
| 39 | MAP3K3 | 1.25617927 |
| 40 | KDR | 1.25038613 |
| 41 | MARK3 | 1.24565089 |
| 42 | CCNB1 | 1.17066118 |
| 43 | PRKCH | 1.16679339 |
| 44 | STK38L | 1.16443868 |
| 45 | TAOK3 | 1.15538946 |
| 46 | PIK3CA | 1.14823538 |
| 47 | PDK3 | 1.10995425 |
| 48 | PDK4 | 1.10995425 |
| 49 | MYLK | 1.09612512 |
| 50 | BCR | 1.07597284 |
| 51 | MAPK12 | 1.05289446 |
| 52 | MKNK2 | 1.05070389 |
| 53 | ZAK | 1.04586779 |
| 54 | FER | 1.02125816 |
| 55 | PHKG1 | 1.02059747 |
| 56 | PHKG2 | 1.02059747 |
| 57 | STK39 | 1.01759551 |
| 58 | WNK4 | 1.01055170 |
| 59 | MAP2K7 | 0.99218446 |
| 60 | GSK3A | 0.98770823 |
| 61 | HIPK2 | 0.96094960 |
| 62 | MINK1 | 0.95598311 |
| 63 | PAK3 | 0.94675649 |
| 64 | MAP3K9 | 0.94654422 |
| 65 | PRKCG | 0.93672573 |
| 66 | EPHA4 | 0.87928620 |
| 67 | RET | 0.87373341 |
| 68 | JAK3 | 0.87146696 |
| 69 | CAMK2A | 0.86109830 |
| 70 | TRIM28 | 0.85893046 |
| 71 | TNIK | 0.83244403 |
| 72 | KSR2 | 0.82518193 |
| 73 | TGFBR1 | 0.81972264 |
| 74 | TXK | 0.80780184 |
| 75 | FGR | 0.80331925 |
| 76 | PDK1 | 0.80120270 |
| 77 | PLK2 | 0.79401338 |
| 78 | PINK1 | 0.78554676 |
| 79 | FLT3 | 0.78500797 |
| 80 | PDPK1 | 0.78250701 |
| 81 | EPHB1 | 0.77794410 |
| 82 | TNK2 | 0.77498260 |
| 83 | ROCK2 | 0.74727639 |
| 84 | CDK9 | 0.74627879 |
| 85 | PAK6 | 0.73995470 |
| 86 | PAK2 | 0.72837877 |
| 87 | PDGFRB | 0.72274076 |
| 88 | MAPK7 | 0.71755710 |
| 89 | CSNK1G1 | 0.71220899 |
| 90 | MAP2K3 | 0.70845889 |
| 91 | SGK3 | 0.70323603 |
| 92 | IRAK1 | 0.70222769 |
| 93 | DYRK2 | 0.68473248 |
| 94 | CSNK1G2 | 0.68255586 |
| 95 | MKNK1 | 0.67278406 |
| 96 | ERBB2 | 0.67049531 |
| 97 | TEC | 0.66705202 |
| 98 | PKN1 | 0.66623215 |
| 99 | DMPK | 0.65656594 |
| 100 | NTRK3 | 0.64642036 |
| 101 | CAMKK1 | 0.64618276 |
| 102 | LATS2 | 0.64264875 |
| 103 | MAP3K7 | 0.64219658 |
| 104 | MAP2K4 | 0.64079451 |
| 105 | CAMK1 | 0.63811419 |
| 106 | JAK1 | 0.62341975 |
| 107 | AKT3 | 0.61767032 |
| 108 | PRKD1 | 0.61635274 |
| 109 | CSNK1A1 | 0.61528938 |
| 110 | MAPKAPK5 | 0.61519995 |
| 111 | PAK4 | 0.61286891 |
| 112 | STK38 | 0.59638841 |
| 113 | STK3 | 0.57837770 |
| 114 | UHMK1 | 0.56817728 |
| 115 | ERBB3 | 0.56787879 |
| 116 | KIT | 0.56188068 |
| 117 | CDK19 | 0.55975497 |
| 118 | ADRBK1 | 0.54973051 |
| 119 | CAMKK2 | 0.54591214 |
| 120 | FGFR1 | 0.52164236 |
| 121 | PRKACA | 0.49962639 |
| 122 | NEK1 | 0.49151026 |
| 123 | DAPK2 | 0.48812393 |
| 124 | NEK6 | 0.48754652 |
| 125 | RPS6KB2 | 0.48684915 |
| 126 | JAK2 | 0.48201589 |
| 127 | CSNK1A1L | 0.47480196 |
| 128 | INSRR | 0.46535169 |
| 129 | GRK5 | 0.46106005 |
| 130 | PRKCA | 0.45776807 |
| 131 | CAMK2D | 0.45404646 |
| 132 | CAMK1D | 0.44564504 |
| 133 | PRKD3 | 0.44559290 |
| 134 | CDK5 | 0.44250129 |
| 135 | EIF2AK3 | 0.44142057 |
| 136 | SGK1 | 0.43736709 |
| 137 | SRC | 0.43243503 |
| 138 | EPHB2 | 0.42938075 |
| 139 | PRKAA2 | 0.42885105 |
| 140 | PRKCQ | 0.42716964 |
| 141 | FYN | 0.41792121 |
| 142 | ERBB4 | 0.41353084 |
| 143 | EGFR | 0.41094126 |
| 144 | BRD4 | 0.40724319 |
| 145 | CAMK2B | 0.40658089 |
| 146 | PRKCE | 0.40291170 |
| 147 | TAF1 | 0.40268802 |
| 148 | INSR | 0.40093671 |
| 149 | CSNK1D | 0.39511923 |
| 150 | MARK1 | 0.38900423 |
| 151 | IGF1R | 0.38629856 |
| 152 | PRKG1 | 0.38454365 |
| 153 | ERN1 | 0.38082034 |
| 154 | ITK | 0.37827068 |
| 155 | STK11 | 0.37586317 |
| 156 | DYRK1A | 0.37210983 |
| 157 | LMTK2 | 0.36217840 |
| 158 | ROCK1 | 0.36142192 |
| 159 | BCKDK | 0.35793929 |
| 160 | TYRO3 | 0.35144324 |
| 161 | MAPK4 | 0.35095855 |
| 162 | CAMK4 | 0.34354440 |
| 163 | PTK2B | 0.34016092 |
| 164 | CSNK1G3 | 0.33570218 |
| 165 | AKT2 | 0.33245913 |
| 166 | PRKCZ | 0.32951312 |
| 167 | MAP2K1 | 0.32610213 |
| 168 | PRKAA1 | 0.31855714 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Retinol metabolism_Homo sapiens_hsa00830 | 7.17594532 |
| 2 | Phototransduction_Homo sapiens_hsa04744 | 4.74917506 |
| 3 | Tyrosine metabolism_Homo sapiens_hsa00350 | 4.70310040 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.28990417 |
| 5 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.11121135 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 3.00512314 |
| 7 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.87124730 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.49998685 |
| 9 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.39993619 |
| 10 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.10257200 |
| 11 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.97545747 |
| 12 | Bile secretion_Homo sapiens_hsa04976 | 1.82013793 |
| 13 | Taste transduction_Homo sapiens_hsa04742 | 1.81987709 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.80450517 |
| 15 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.77748842 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 1.76223762 |
| 17 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.75443993 |
| 18 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.73619326 |
| 19 | Melanogenesis_Homo sapiens_hsa04916 | 1.73129591 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.69071894 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.55448813 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.55313775 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.54198528 |
| 24 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.51221445 |
| 25 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.50431647 |
| 26 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.46019438 |
| 27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.41873960 |
| 28 | Olfactory transduction_Homo sapiens_hsa04740 | 1.38026649 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.31806976 |
| 30 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.26488528 |
| 31 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.26338326 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.25424219 |
| 33 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.22298739 |
| 34 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.18477579 |
| 35 | Tight junction_Homo sapiens_hsa04530 | 1.16861664 |
| 36 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16289959 |
| 37 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.11028187 |
| 38 | Basal transcription factors_Homo sapiens_hsa03022 | 1.08918896 |
| 39 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.08761284 |
| 40 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.06416374 |
| 41 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.03930488 |
| 42 | Salivary secretion_Homo sapiens_hsa04970 | 1.01942083 |
| 43 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.00719234 |
| 44 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.98682362 |
| 45 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.97998319 |
| 46 | Renin secretion_Homo sapiens_hsa04924 | 0.97648735 |
| 47 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.97461772 |
| 48 | Peroxisome_Homo sapiens_hsa04146 | 0.95715257 |
| 49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93911381 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.91534268 |
| 51 | Insulin secretion_Homo sapiens_hsa04911 | 0.90547149 |
| 52 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.90491548 |
| 53 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.82986081 |
| 54 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.82320742 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81743363 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.81576262 |
| 57 | Homologous recombination_Homo sapiens_hsa03440 | 0.80511030 |
| 58 | Circadian entrainment_Homo sapiens_hsa04713 | 0.79647850 |
| 59 | Glioma_Homo sapiens_hsa05214 | 0.79221430 |
| 60 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.77665440 |
| 61 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.76740601 |
| 62 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.74970528 |
| 63 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.74509918 |
| 64 | Long-term potentiation_Homo sapiens_hsa04720 | 0.73579340 |
| 65 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73538155 |
| 66 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.73402479 |
| 67 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.72881490 |
| 68 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.71811295 |
| 69 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.70671376 |
| 70 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70271591 |
| 71 | Focal adhesion_Homo sapiens_hsa04510 | 0.70160439 |
| 72 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69943854 |
| 73 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.69828650 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.69013792 |
| 75 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.66462767 |
| 76 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.65007375 |
| 77 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.61191375 |
| 78 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.60472953 |
| 79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.59815839 |
| 80 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.59325843 |
| 81 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.59000716 |
| 82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.58420471 |
| 83 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.58416997 |
| 84 | GABAergic synapse_Homo sapiens_hsa04727 | 0.57618275 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57149659 |
| 86 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.55897430 |
| 87 | Long-term depression_Homo sapiens_hsa04730 | 0.55517040 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55503076 |
| 89 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.54871001 |
| 90 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.53688593 |
| 91 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.53680436 |
| 92 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.53654220 |
| 93 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.53453268 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | 0.52468742 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.52050423 |
| 96 | RNA degradation_Homo sapiens_hsa03018 | 0.51579322 |
| 97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.51085896 |
| 98 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.49859363 |
| 99 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.49716643 |
| 100 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.49097343 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48474186 |
| 102 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46903756 |
| 103 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46708260 |
| 104 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.46264960 |
| 105 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.45355263 |
| 106 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.45039467 |
| 107 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.44097825 |
| 108 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43265402 |
| 109 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43229858 |
| 110 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42608132 |
| 111 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.42110654 |
| 112 | Cocaine addiction_Homo sapiens_hsa05030 | 0.42041258 |
| 113 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.41351147 |
| 114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.41297343 |
| 115 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.39763492 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39295160 |
| 117 | ABC transporters_Homo sapiens_hsa02010 | 0.38842894 |
| 118 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.37872577 |
| 119 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36740292 |
| 120 | Mineral absorption_Homo sapiens_hsa04978 | 0.36406034 |
| 121 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.35613957 |
| 122 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.34823019 |
| 123 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32918104 |
| 124 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.32775871 |
| 125 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.32321360 |
| 126 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.32012848 |
| 127 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.31809244 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31510781 |
| 129 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.31162284 |
| 130 | Adherens junction_Homo sapiens_hsa04520 | 0.30927595 |
| 131 | Carbon metabolism_Homo sapiens_hsa01200 | 0.30487915 |
| 132 | Axon guidance_Homo sapiens_hsa04360 | 0.28833142 |
| 133 | Insulin resistance_Homo sapiens_hsa04931 | 0.28712966 |
| 134 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.27803063 |
| 135 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.27771385 |
| 136 | Purine metabolism_Homo sapiens_hsa00230 | 0.27441470 |
| 137 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.27166228 |
| 138 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.26864783 |
| 139 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.26707862 |
| 140 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.26345285 |
| 141 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.25612607 |
| 142 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25384264 |
| 143 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.25150417 |
| 144 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.24870523 |
| 145 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.24529739 |

